Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease

被引：0
作者：
Jassim Al Suwaidi
Amar M Salam
机构：
[1] Hamad Medical Corporation,Department of Cardiology and Cardiovascular Surgery
来源：
Trials | / 2卷 / 4期
关键词：
coronary artery disease; glycoprotein IIb/IIIa inhibitors; myocardial infarction; percutaneous coronary interventions;
D O I：
10.1186/cvm-2-4-171
中图分类号：
学科分类号：
摘要：
Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous and the oral forms. In this review, we present a systematic overview of these trials.
引用
收藏
相关论文
共 226 条
[1]  
Fuster V(1992)The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med 326 242-250
[2]  
Badimon L(1992)The pathogenesis of coronary artery disease and the acute coronary syndromes (part II). N Engl J Med 326 310-318
[3]  
Badimon JJ(1985)Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model. Circulation Res 57 105-112
[4]  
Chesebro JH(2000)Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 35 1103-1115
[5]  
Fuster V(1994)Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330 956-961
[6]  
Badimon L(1997)Platelet glycoprotein IIb/IIIa blockade with abciximab with low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336 1689-1696
[7]  
Badimon JJ(1997)Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet 349 1429-1435
[8]  
Chesebro JH(1998)Randomized placebo-controlled and balloon-angioplasty controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet 352 87-92
[9]  
Steele PM(1999)Complementary clinical benefits of coronary artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. N Engl J Med 341 319-327
[10]  
Chesebro JH(1999)Enhanced survival with platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: 1 year outcomes and health care economic implications from a multicenter, randomized trial. Lancet 354 2019-2024
12345678910